bimatoprost


Also found in: Wikipedia.

bimatoprost

 [bĭ-mat´o-prost]
a synthetic prostaglandin analogue that acts as an ocular hypotensive; applied topically to the conjunctiva in the treatment of open-angle glaucoma and ocular hypertension.

bimatoprost

/bi·mat·o·prost/ (bĭ-mat´o-prost) a synthetic prostaglandin analogue used topically in the treatment of open-angle glaucoma and ocular hypertension.

bimatoprost

[b-mat′o-prost]
a synthetic prostaglandin analogue that acts as an ocular hypotensive; applied topically to the conjunctiva in the treatment of open-angle glaucoma and ocular hypertension.

bimatoprost

A synthetic PROSTAGLANDIN drug used as eye drops to control raised intraocular pressure in GLAUCOMA. A brand name is Lumigan.

prostaglandin analogues 

Drugs used in the treatment of open-angle glaucoma or ocular hypertension. At specific dosages they lower the intraocular pressure (IOP), supposedly by increasing the outflow of aqueous humour via the uveoscleral pathway. Common agents include latanoprost, travoprost, bimatoprost (a synthetic prostamide structurally related to prostaglandin) and unoprostone isopropyl. Bimatoprost reduces IOP by increasing the uveoscleral outflow as well as the trabecular outflow.
References in periodicals archive ?
The Phase 2 results comprise data from 130 subjects and were collected from ten clinical sites in the Unites States in a randomized, double-masked, active-controlled trial of the bimatoprost ocular insert compared to twice-daily timolol eye drops.
Market Research Report on Global and Chinese Bimatoprost Industry, 2009-2019 ( http://www.
004% (Travatan, Alcon) in December 2001 and the prostamide, bimatoprost 0.
The new research suggests the active ingredient in Lumigan, bimatoprost, has the same effect on the scalp.
A new research report shows how the FDA-approved glaucoma drug, bimatoprost, causes human hair to regrow.
The FDA-approved glaucoma drug, bimatoprost, causes human hair to re-grow and has been commercially available as a way to lengthen eyelashes, but these data are the first to show that it can actually grow human hair from the scalp.
Its main ingredient, bimatoprost, was initially used to treat glaucoma, a serious eye disease that can lead to blindness, and it's mainly prescribed for that, but in a higher dose.
In November, the pharmaceutical company filed a lawsuit against Jan Marini and several of its competitors, alleging they were infringing on Allergan's patent on bimatoprost, Lumigan's main ingredient.
Latanoprost (Xalatan), Travoprost (Travatan) and Bimatoprost (Lumigan) are new medications in this class used for glaucoma and hypertension of the eye.
In the 1990s, a drug for glaucoma was approved by the FDA - bimatoprost, 0.
Phase I/II Interim Data Show Implant was Tolerated and is Comparable to Daily Topical Bimatoprost in Efficacy-